News | September 09, 2007

FDA Approves Chlorascrub Swabstick, Maxi Swabstick for Inclusion in Kits

September 10, 2007 - PDI recently announced the FDA approval of Chlorascrub Swabstick and Maxi Swabstick, the only 3.15 percent Chlorhexidine Gluconate (w/v) and 70 percent Isopropyl Alcohol (v/v) pre-injection skin antiseptic for inclusion in kits.

Recognizing the need for clinicians to have the convenience of kits for a variety of medical procedures, PDI, the Healthcare Division of Nice-Pak Products Inc., has now made its Chlorascrub Swabstick and Maxi Swabstick available to kit manufacturers. The Chlorascrub Swab was approved for kit use earlier this year.

The Chlorascrub Swabstick and Maxi Swabstick packaging has been specifically designed to withstand the Ethylene Oxide (EtO) sterilization process for the manufacture of finished sterile kits. PDI will also continue to market its current FDA-approved non-kit Chlorascrub Swab, Swabstick and Maxi Swabstick products.

Chlorascrub, available as Swab, Swabstick and Maxi Swabstick, is the optimal, cost-effective delivery system for pre-injection skin preparation. The product achieves a >2 log10reduction in 30 seconds and maintains a >2 log10reduction for at least 24 hours.

For more information: